Joint Filing Agreement
Exhibit 99.1
In accordance with Rule 13d-1(f) under the Securities and Exchange Act of 1934, the persons or entities named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the shares of NewAmsterdam Pharma Company N.V. and further agree that this joint filing agreement be included as an exhibit to this Schedule 13D. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement as of December 1, 2022.
XXXXXXX LIFE SCIENCES X, L.P. | ||
By FHMLS X, L.P., its general partner | ||
By FHMLS X, L.L.C., its general partner | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
FHMLS X, L.P. | ||
By FHMLS X, L.L.C., its general partner | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
FHMLS X, L.L.C. | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
XXXXXXX LIFE SCIENCES XI, L.P. | ||
By FHMLS XI, L.P., its general partner | ||
By FHMLS XI, L.L.C., its general partner | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
FHMLS XI, L.P. | ||
By FHMLS XI, L.L.C., its general partner | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
FHMLS XI, L.L.C. | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
XXXXXXX LIFE SCIENCES PUBLIC FUND, L.P. | ||
By FHMLSP, L.P., its general partner | ||
By FHMLSP, L.L.C., its general partner | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director |
FHMLSP, L.P. | ||
By FHMLSP, L.L.C., its general partner | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
FHMLSP, L.L.C. | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
XXXXXXX LIFE SCIENCES OVERAGE FUND, L.P. | ||
By FHMLSP Overage, L.P., its general partner | ||
By FHMLSP Overage, L.L.C., its general partner | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
FHMLSP OVERAGE, L.P. | ||
By FHMLSP Overage, L.L.C., its general partner | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
FHMLS OVERAGE, L.L.C. | ||
By: | * | |
Xxxxx X. Xxxxxx, Managing Director | ||
By: | * | |
Xxxxx Xxxxx | ||
By: | * | |
Xxxxxx Xxx | ||
*By: | * | |
Xxx Xxxxx | ||
By: | * | |
Xxxxxxx X. Xxxxx | ||
*By: | /s/ Xxxxx X. Xxxxxx | |
Xxxxx X. Xxxxxx, as Attorney-in-Fact |
This agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, copies of which were filed with the SEC on December 1, 2022.